REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 113 filers reported holding REVANCE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $13,459,131 | -38.4% | 729,097 | -9.8% | 0.38% | -40.4% |
Q3 2022 | $21,834,000 | +176.0% | 808,671 | +41.2% | 0.63% | +155.6% |
Q2 2022 | $7,912,000 | +195.0% | 572,514 | +316.3% | 0.25% | +359.3% |
Q1 2022 | $2,682,000 | +66.8% | 137,514 | +108.9% | 0.05% | +107.7% |
Q2 2020 | $1,608,000 | -88.3% | 65,839 | -92.9% | 0.03% | -92.7% |
Q1 2020 | $13,690,000 | +2.8% | 925,000 | +12.8% | 0.36% | +35.2% |
Q4 2019 | $13,315,000 | -30.2% | 820,377 | +32.5% | 0.26% | -50.6% |
Q1 2018 | $19,064,000 | +33.3% | 618,957 | +54.7% | 0.53% | +12.7% |
Q4 2017 | $14,300,000 | – | 400,000 | – | 0.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |